{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:19:33Z","timestamp":1790093973507,"version":"4.0.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101539","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:02:18Z","timestamp":1724371338000},"page":"101539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-5275","authenticated-orcid":false,"given":"Maria Stella","family":"Franz\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6286-3272","authenticated-orcid":false,"given":"Paul","family":"Vigneron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chalaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Tacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6810-9406","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Regnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancuta","family":"Bejan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Rhaiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Sommacale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Brustia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Amaddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0001","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0002","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm8010055","article-title":"History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma","volume":"8","author":"Saini","year":"2019","journal-title":"JCM"},{"issue":"11","key":"10.1016\/j.aohep.2024.101539_bib0004","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00270-022-03072-8","article-title":"TARE in hepatocellular carcinoma: from the right to the left of BCLC","volume":"45","author":"Guiu","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0005","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/S1470-2045(23)00186-9","article-title":"Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept","volume":"24","author":"Vitale","year":"2023","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000218349","article-title":"Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres","volume":"27","author":"Sangro","year":"2009","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0008","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"issue":"43","key":"10.1016\/j.aohep.2024.101539_bib0009","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.3748\/wjg.v27.i43.7462","article-title":"Hepatocellular carcinoma locoregional therapies: outcomes and future horizons","volume":"27","author":"Makary","year":"2021","journal-title":"WJG"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2024.101539_bib0011","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"68","author":"Spreafico","year":"2018","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0012","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jvir.2018.03.018","article-title":"Radioembolization for hepatocellular carcinoma: a nationwide 10-year experience","volume":"29","author":"Tohme","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0013","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/curroncol28010095","article-title":"Predictors of complete response in patients with hepatocellular carcinoma treated with trans-arterial radioembolization","volume":"28","author":"Kim","year":"2021","journal-title":"Current Oncology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0014","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000348325","article-title":"Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90","volume":"84","author":"Lau","year":"2013","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.aohep.2024.101539_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000123319.20705.92","article-title":"Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis","volume":"15","author":"Salem","year":"2004","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100633","article-title":"Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: results from the prospective CIRT study","volume":"5","author":"Kolligs","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1016\/j.aohep.2024.101539_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/827649","article-title":"Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization: preliminary results","volume":"2013","author":"Pracht","year":"2013","journal-title":"Int J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0019","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2967\/jnumed.114.145177","article-title":"Personalized dosimetry with intensification using 90 Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis","volume":"56","author":"Garin","year":"2015","journal-title":"J Nucl Med"},{"issue":"23","key":"10.1016\/j.aohep.2024.101539_bib0021","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2217\/fon.15.267","article-title":"Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate\u2013advanced hepatocellular carcinoma","volume":"11","author":"Golfieri","year":"2015","journal-title":"Future Oncol"},{"issue":"12","key":"10.1016\/j.aohep.2024.101539_bib0022","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jvir.2020.06.027","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion: validation of the milan prognostic score","volume":"31","author":"Bargellini","year":"2020","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jhep.2018.02.027","article-title":"Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"69","author":"Mosconi","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0024","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhep.2012.09.003","article-title":"Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression","volume":"58","author":"Memon","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101539_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00259-015-3210-7","article-title":"Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis","volume":"43","author":"Edeline","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154986","article-title":"Radioembolization is a safe and effective treatment for hepatocellular carcinoma with portal vein thrombosis: a propensity score analysis. Avila MA, editor","volume":"11","author":"Cho","year":"2016","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0027","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/RLU.0b013e3182867f17","article-title":"Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT","volume":"38","author":"Kucuk","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"47","key":"10.1016\/j.aohep.2024.101539_bib0028","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.3748\/wjg.v22.i47.10406","article-title":"Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization","volume":"22","author":"Abuodeh","year":"2016","journal-title":"WJG"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0029","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.21.26485","article-title":"Utility of early posttreatment PET\/CT evaluation using FDG or 18 F-FCH to predict response to 90 Y radioembolization in patients with hepatocellular carcinoma","volume":"218","author":"Reizine","year":"2022","journal-title":"Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00259-017-3653-0","article-title":"18F-FDG PET\/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma","volume":"44","author":"Jreige","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.aohep.2024.101539_bib0031","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2967\/jnumed.115.158758","article-title":"Evaluating treatment response of radioembolization in intermediate-stage hepatocellular carcinoma patients using 18 FFluoroethylcholine PET\/CT","volume":"56","author":"Hartenbach","year":"2015","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.aohep.2024.101539_bib0032","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3390\/biomedicines10112996","article-title":"PET\/CT with 18F-choline or 18F-FDG in hepatocellular carcinoma submitted to 90Y-TARE: a real-world study","volume":"10","author":"Filippi","year":"2022","journal-title":"Biomedicines"},{"issue":"24","key":"10.1016\/j.aohep.2024.101539_bib0033","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.3390\/jcm11247469","article-title":"Improved survival after transarterial radioembolisation for hepatocellular carcinoma gives the procedure added value","volume":"11","author":"Mosconi","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.aohep.2024.101539_bib0034","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3748\/wjg.v28.i4.432","article-title":"Sarcopenia in hepatocellular carcinoma: current knowledge and future directions","volume":"28","author":"Perisetti","year":"2022","journal-title":"WJG"},{"key":"10.1016\/j.aohep.2024.101539_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108889","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma: outcome prediction with MRI derived fat-free muscle area","volume":"125","author":"Faron","year":"2020","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1016\/j.aohep.2024.101539_bib0036","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00270-021-02874-6","article-title":"MRI-derived sarcopenia associated with increased mortality following yttrium-90 radioembolization of hepatocellular carcinoma","volume":"44","author":"Guichet","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.aohep.2024.101539_bib0037","first-page":"728","article-title":"Sarcopenia worsening one month after transarterial radioembolization predicts progressive disease in patients with advanced hepatocellular carcinoma","volume":"10","author":"Vallati","year":"2021","journal-title":"Biology (Basel)"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0038","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MEG.0000000000002117","article-title":"Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience","volume":"33","author":"Ekmekcioglu","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0039","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/07357907.2020.1870126","article-title":"Association between curative treatment after transarterial radioembolization and better survival outcomes in patients with hepatocellular carcinoma","volume":"39","author":"Kim","year":"2021","journal-title":"Cancer Invest"},{"issue":"8","key":"10.1016\/j.aohep.2024.101539_bib0040","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jvir.2019.03.016","article-title":"Alpha-fetoprotein, des-gamma-carboxy prothrombin, and modified RECIST response as predictors of survival after transarterial radioembolization for hepatocellular carcinoma","volume":"30","author":"Lim","year":"2019","journal-title":"J Vasc Interv Radiol"},{"issue":"21","key":"10.1016\/j.aohep.2024.101539_bib0041","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.3390\/cancers13215427","article-title":"Liver decompensation as late complication in HCC patients with long-term response following selective internal radiation therapy","volume":"13","author":"Van Doorn","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.aohep.2024.101539_bib0042","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers13153794","article-title":"ALBI score is a strong predictor of toxicity following SIRT for hepatocellular carcinoma","volume":"13","author":"Lescure","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0043","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jvir.2016.03.005","article-title":"Independent analysis of albumin-bilirubin grade in a 765-patient cohort treated with transarterial locoregional therapy for hepatocellular carcinoma","volume":"27","author":"Hickey","year":"2016","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0044","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers11060879","article-title":"Prognostic role of albumin, bilirubin, and ALBI scores: analysis of 1000 patients with hepatocellular carcinoma undergoing radioembolization","volume":"11","author":"Antkowiak","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.aohep.2024.101539_bib0045","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/COC.0000000000000384","article-title":"Assessment of the albumin-bilirubin (ALBI) grade as a prognostic indicator for hepatocellular carcinoma patients treated with radioembolization","volume":"41","author":"Gui","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0046","doi-asserted-by":"crossref","first-page":"840","DOI":"10.21037\/jgo.2018.05.14","article-title":"Using the albumin-bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma","volume":"9","author":"Mohammadi","year":"2018","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0047","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00270-019-02191-z","article-title":"Prognosticating survival in hepatocellular carcinoma with elevated baseline alpha-fetoprotein treated with radioembolization using a novel laboratory scoring system: initial development and validation","volume":"42","author":"Ali","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0048","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10620-020-06245-y","article-title":"Selective internal radiation therapy for hepatocellular carcinoma across the barcelona clinic liver cancer stages","volume":"66","author":"Moctezuma-Velazquez","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.aohep.2024.101539_bib0049","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1002\/hep4.2072","article-title":"Hepatic decompensation after transarterial radioembolization: a retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma","volume":"6","author":"Reincke","year":"2022","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.hpb.2017.01.013","article-title":"Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma","volume":"19","author":"Taussig","year":"2017","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0051","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MNM.0000000000001122","article-title":"Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma","volume":"41","author":"Soydal","year":"2020","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0052","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jvir.2015.01.038","article-title":"The prognostic role of neutrophilto-lymphocyte ratio in patients with unresectable hepatocellular carcinoma treated with radioembolization","volume":"26","author":"Sukato","year":"2015","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101539_bib0053","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00270-022-03080-8","article-title":"Inflammatory scores: correlation with clinical outcomes in hepatocellular carcinoma patients undergoing transarterial radioembolization","volume":"45","author":"Young","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.aohep.2024.101539_bib0054","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00270-020-02467-9","article-title":"Lymphocytes and neutrophil-to-lymphocyte ratio variations after selective internal radiation treatment for HCC: a retrospective cohort study","volume":"43","author":"Estrade","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.aohep.2024.101539_bib0055","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1007\/s00259-020-05186-y","article-title":"Prognostic significance of neutrophil to lymphocyte ratio dynamics in patients with hepatocellular carcinoma treated with radioembolization using glass microspheres","volume":"48","author":"Li","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0056","first-page":"269","article-title":"Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy","volume":"7","author":"D'Emic","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101539_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100995","article-title":"Predictive value of platelet-tolymphocyte and neutrophil-to-lymphocyte ratio in HCC treated with sorafenib and radioembolization","volume":"6","author":"Ocal","year":"2024","journal-title":"JHEP Reports"},{"key":"10.1016\/j.aohep.2024.101539_bib0058","doi-asserted-by":"crossref","DOI":"10.20517\/2394-5079.2020.57","article-title":"Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma","author":"Yoneoka","year":"2020","journal-title":"HR [Internet]"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0059","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1158\/1055-9965.EPI-14-0146","article-title":"Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"23","author":"Templeton","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jss.2015.05.003","article-title":"Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma","volume":"198","author":"Li","year":"2015","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0061","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/ijms19061766","article-title":"IL-6 and IL-8 serum levels predict tumor response and overall survival after TACE for primary and secondary hepatic malignancies","volume":"19","author":"Loosen","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.aohep.2024.101539_bib0062","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00270-017-1622-4","article-title":"Cytokines and 90YRadioembolization: relation to liver function and overall survival","volume":"40","author":"Seidensticker","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0063","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13550-021-00791-w","article-title":"Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization","volume":"11","author":"Ocal","year":"2021","journal-title":"EJNMMI Res"},{"issue":"9","key":"10.1016\/j.aohep.2024.101539_bib0064","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jvir.2016.03.043","article-title":"Angiogenic response following radioembolization: results from a randomized pilot study of yttrium-90 with or without sorafenib","volume":"27","author":"Lewandowski","year":"2016","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"10.1016\/j.aohep.2024.101539_bib0065","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00259-019-04340-5","article-title":"Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group","volume":"46","author":"Salem","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0066","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00259-013-2395-x","article-title":"Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept","volume":"40","author":"Garin","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0067","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/liv.13220","article-title":"High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization","volume":"37","author":"Garin","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0068","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation\u2013absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90 Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0069","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0070","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","author":"Levillain","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.aohep.2024.101539_bib0071","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol.Phys."},{"issue":"10","key":"10.1016\/j.aohep.2024.101539_bib0072","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00270-018-2008-y","article-title":"Radioembolization super survivors: extended survival in non-operative hepatocellular carcinoma","volume":"41","author":"Gordon","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101539_bib0073","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/cancers12071914","article-title":"Locoregional therapy approaches for hepatocellular carcinoma: recent advances and management strategies","volume":"12","author":"Makary","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.aohep.2024.101539_bib0074","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jhep.2013.06.015","article-title":"Radiation lobectomy: timedependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection","volume":"59","author":"Vouche","year":"2013","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0076","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jvir.2017.02.018","article-title":"Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score\u2013matched study","volume":"28","author":"Padia","year":"2017","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0077","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1245\/s10434-009-0454-0","article-title":"Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization","volume":"16","author":"Gaba","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101539_bib0078","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jvir.2021.01.281","article-title":"Induction of contralateral hepatic hypertrophy by unilobar yttrium-90 transarterial radioembolization versus portal vein embolization: an animal study","volume":"32","author":"Liebl","year":"2021","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0079","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.26947","article-title":"Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization: garlipp et al","volume":"59","author":"Garlipp","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0080","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.surg.2020.12.012","article-title":"A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma","volume":"169","author":"Bekki","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.aohep.2024.101539_bib0081","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmp.2021.07.032","article-title":"Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres","volume":"89","author":"d'Abadie","year":"2021","journal-title":"Physica Med"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0082","first-page":"168","article-title":"Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan","volume":"55","author":"Chiesa","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.aohep.2024.101539_bib0083","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.111.094235","article-title":"Dosimetry based on 99mTcmacroaggregated albumin SPECT\/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results","volume":"53","author":"Garin","year":"2012","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.aohep.2024.101539_bib0084","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1007\/s00330-023-09390-w","article-title":"Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT\/CT anatomical and volumetric results during the planification of radioembolization for HCC","volume":"33","author":"Derbel","year":"2023","journal-title":"Eur Radiol"},{"issue":"23","key":"10.1016\/j.aohep.2024.101539_bib0085","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.3390\/jcm11237245","article-title":"Theranostic approach in SIRT: value of pre-therapy imaging in treatment planning","volume":"11","author":"d'Abadie","year":"2022","journal-title":"J Clin Med"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:40:26Z","timestamp":1777783226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124003338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124003338"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101539","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101539"}}